The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery.

Baroud, Milad; Lepeltier, Elise; Thepot, Sylvain; El-Makhour, Yolla; Duval, Olivier

Baroud, Milad; Lepeltier, Elise; Thepot, Sylvain; El-Makhour, Yolla; Duval, Olivier.

Afiliación

Baroud M; Micro et Nanomédecines Translationnelles, MINT, UNIV Angers, UMR INSERM 1066, UMR CNRS 6021 Angers France elise.lepeltier@univ-angers.fr.
Lepeltier E; Micro et Nanomédecines Translationnelles, MINT, UNIV Angers, UMR INSERM 1066, UMR CNRS 6021 Angers France elise.lepeltier@univ-angers.fr.
Thepot S; University Hospital of Angers, Hematology 49933 Angers France.
El-Makhour Y; Université d'Angers, Inserm, CRCINA 49000 Angers France.
Duval O; Fédération Hospitalo-Universitaire 'Grand Ouest Against Leukemia' (FHU GOAL) France.

Nanoscale Adv ; 3(8): 2157-2179, 2021 Apr 20.

Article en En | MEDLINE | ID: mdl-36133769

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nanoscale Adv Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google